NEW YORK--(BUSINESS WIRE)--Lev Pharmaceuticals, Inc. (OTCBB: LEVP.OB) today announced that it has entered into a strategic supply agreement with Plasma Centers of America, LLC to construct and purchase a maximum of three plasma collection centers in the U.S. with exclusive rights to make periodic purchases of U.S. source plasma from each new collection center through December 31, 2010.
